VISCA, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 29.574
EU - Europa 26.061
AS - Asia 17.417
SA - Sud America 1.944
AF - Africa 523
OC - Oceania 63
Continente sconosciuto - Info sul continente non disponibili 17
Totale 75.599
Nazione #
US - Stati Uniti d'America 29.158
CN - Cina 7.932
DK - Danimarca 5.251
SG - Singapore 5.216
GB - Regno Unito 4.993
RU - Federazione Russa 4.211
IT - Italia 2.912
NL - Olanda 2.163
VN - Vietnam 1.669
DE - Germania 1.638
BR - Brasile 1.472
SE - Svezia 1.400
UA - Ucraina 1.188
FI - Finlandia 636
HK - Hong Kong 500
FR - Francia 398
IE - Irlanda 388
TR - Turchia 356
IN - India 351
AL - Albania 316
KR - Corea 308
BD - Bangladesh 268
CA - Canada 245
AR - Argentina 175
JP - Giappone 133
SN - Senegal 119
IQ - Iraq 106
CI - Costa d'Avorio 103
ID - Indonesia 103
MX - Messico 96
AT - Austria 78
PL - Polonia 74
ZA - Sudafrica 70
CH - Svizzera 65
EC - Ecuador 65
ES - Italia 63
PK - Pakistan 62
CO - Colombia 61
AU - Australia 54
BE - Belgio 52
MA - Marocco 50
MY - Malesia 49
VE - Venezuela 49
UZ - Uzbekistan 48
CZ - Repubblica Ceca 42
LT - Lituania 40
PH - Filippine 40
SA - Arabia Saudita 38
CL - Cile 35
RO - Romania 33
TN - Tunisia 33
PY - Paraguay 29
TH - Thailandia 29
KE - Kenya 28
PE - Perù 27
EG - Egitto 25
IR - Iran 23
AE - Emirati Arabi Uniti 20
ET - Etiopia 20
IL - Israele 20
NG - Nigeria 20
PT - Portogallo 19
JO - Giordania 17
KZ - Kazakistan 17
RS - Serbia 17
DZ - Algeria 15
NP - Nepal 15
AZ - Azerbaigian 14
OM - Oman 14
BO - Bolivia 13
HU - Ungheria 13
KG - Kirghizistan 13
LV - Lettonia 13
UY - Uruguay 13
GR - Grecia 11
CR - Costa Rica 10
LY - Libia 10
PS - Palestinian Territory 10
DO - Repubblica Dominicana 9
JM - Giamaica 9
PA - Panama 9
BG - Bulgaria 8
GE - Georgia 8
HN - Honduras 8
HR - Croazia 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AO - Angola 7
MD - Moldavia 7
NZ - Nuova Zelanda 7
GT - Guatemala 6
TT - Trinidad e Tobago 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
EU - Europa 4
KW - Kuwait 4
LB - Libano 4
MK - Macedonia 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
XK - ???statistics.table.value.countryCode.XK??? 4
Totale 75.515
Città #
Southend 4.447
Fairfield 3.169
Woodbridge 2.970
Singapore 2.506
Ashburn 2.365
Amsterdam 1.912
Houston 1.861
Wilmington 1.779
Ann Arbor 1.721
Chandler 1.596
San Jose 1.321
Seattle 1.285
Nanjing 1.100
Cambridge 1.099
Beijing 1.033
Dearborn 889
Boardman 847
Jacksonville 776
Dallas 766
Hefei 632
Rome 608
Princeton 597
Hong Kong 483
Shenyang 434
Ho Chi Minh City 422
Jinan 413
Nanchang 393
Dublin 384
Dong Ket 378
Plano 347
Hebei 322
Helsinki 302
Seoul 297
Hanoi 291
Moscow 290
New York 269
Los Angeles 264
Changsha 255
Redwood City 237
Tianjin 218
Jiaxing 215
Izmir 192
Milan 187
San Diego 181
Zhengzhou 177
The Dalles 164
São Paulo 160
Frankfurt am Main 158
Shanghai 157
Munich 145
Bremen 138
Kunming 135
Hangzhou 131
Guangzhou 130
Ningbo 125
Tokyo 121
Dakar 117
Altamura 114
London 109
Santa Clara 103
Istanbul 100
Mumbai 100
San Mateo 96
Paris 89
Montreal 83
Orem 80
San Paolo di Civitate 80
Taizhou 78
Orange 77
Taiyuan 73
Chicago 71
Naples 70
Council Bluffs 68
Haikou 63
Haiphong 61
Warsaw 60
Fuzhou 57
Da Nang 56
Brooklyn 53
Chennai 49
Columbus 49
Falkenstein 48
Atlanta 45
Baghdad 45
Brussels 45
Tashkent 45
Stockholm 43
Bologna 41
Toronto 41
Boston 40
San Francisco 40
Denver 39
Phoenix 39
Turin 39
Norwalk 37
Mexico City 36
Buffalo 35
Johannesburg 35
Rio de Janeiro 34
Biên Hòa 33
Totale 46.510
Nome #
THE EFFECT OF SATURATION WITH ZN-2+ AND OTHER METAL-IONS ON THE ANTIBACTERIAL ACTIVITY OF OVOTRANSFERRIN 2.084
Trasporto di ferro, formazione di biofilm e virulenza in Pseudomonas aeruginosa 1.259
5-FLUOROCITOSINA COME AGENTE ANTIBATTERICO 631
Drug repurposing for antivirulence therapy against opportunistic bacterial pathogens 385
Acinetobacter baumannii biofilm formation in Human serum and disruption by gallium 350
Biodeterioration of mural paintings in a rocky habitat: The Crypt of the Original Sin (Matera, Italy) 332
A pilot clinical trial on a new point-of-care test for the diagnosis and fast management of urinary tract infections in the Emergency Department. 329
A new device for the prompt diagnosis of urinary tract infections. 327
Antivirulence activity of azithromycin in Pseudomonas aeruginosa 327
A new transcriptional repressor of the Pseudomonas aeruginosa quorum sensing receptor gene lasR. 319
A New Method For Microbiological Analysis That Could Be Used For Point-Of-Care Testing (POCT) 314
Identification by High-Throughput Screening of Pseudomonas Acyl-Coenzyme A Synthetase Inhibitors 302
A multitask biosensor for micro-volumetric detection of N-3-oxo-dodecanoyl-homoserine lactone quorum sensing signal 302
A multitask biosensor for micro-volumetric detection of N-3-oxo-dodecanoyl-homoserine lactone quorum sensing signal 293
ANTIFUNGAL ACTIVITY OF OVOTRANSFERRIN TOWARDS GENUS CANDIDA 292
Effect of efflux pump inhibition on Pseudomonas aeruginosa transcriptome and virulence 292
Acinetobacter Infection - an Emerging Threat to Human Health 289
Biocompatibility and antibacterial properties of TiCu(Ag) thin films produced by physical vapor deposition magnetron sputtering 289
Ferric Uptake Regulator Fur Is Conditionally Essential in Pseudomonas aeruginosa 288
A new device for the prompt diagnosis of urinary tract infections 286
Acinetobacter baumannii: evolution of a global pathogen 285
New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing. 283
Synthesis and structural characterization of silver nanoparticles stabilized with 3-mercapto-1-propansulfonate and 1-thioglucose mixed thiols for antibacterial applications 283
Celebrating centuries: Pink-pigmented bacteria from rosy patinas in the House of Bicentenary (Herculaneum, Italy) 282
Analysis of the periplasmic proteome of Pseudomonas aeruginosa, a metabolically versatile opportunistic pathogen 280
Analysis of the periplasmic proteome of Pseudomonas aeruginosa, a metabolically versatile opportunistic pathogen 277
The dual personality of iron chelators: growth inhibitors or promoters? 277
Antivirulence activity of azithromycin in Pseudomonas aeruginosa 277
Activity and Impact on Resistance Development of Two Antivirulence Fluoropyrimidine Drugs in Pseudomonas aeruginosa 276
Pyoverdine and proteases affect the response of pseudomonas aeruginosa to gallium in human serum 275
INTERACTION BETWEEN LACTOFERRIN AND OVOTRANSFERRIN AND CANDIDA CELLS 273
Cell aggregation promotes pyoverdine-dependent iron uptake and virulence in Pseudomonas aeruginosa 273
Deciphering the Multifactorial Nature of Acinetobacter baumannii Pathogenicity 272
Microbial community structure and dynamics of dark fire-cured tobacco fermentation 270
Analysis of guazatine mixture by LC and LC-MS and antimycotic activity determination of principal components 265
Biological Characterization and in Vivo Assessment of the Activity of a New Synthetic Macrocyclic Antifungal Compound 264
Gallium-Protoporphyrin IX Inhibits Pseudomonas aeruginosa Growth by Targeting Cytochromes 264
Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection 264
Characterization of a rhodanese from the cyanogenic bacterium Pseudomonas aeruginosa 262
H2O2 AND •NO SCAVENGING BY MYCOBACTERIUM LEPRAE TRUNCATED HEMOGLOBIN O 260
Gallium- and Iron-Pyoverdine Coordination Compounds Investigated by X-ray Photoelectron Spectroscopy and X-ray Absorption Spectroscopy 258
Arthrobacter agilis and rosy discoloration in “Terme del Foro” (Pompeii, Italy) 257
Growth Phase- and Desiccation-Dependent Acinetobacter baumannii Morphology: An Atomic Force Microscopy Investigation 256
Structural Biology of Bacterial Haemophores 255
Pseudobactin biogenesis in the plant growth-promoting rhizobacterium Pseudomonas strain B10: Identification and functional analysis of the L-Ornithine N-5-oxygenase (psbA) gene 255
Understanding the biomimetic properties of Gallium in Pseudomonas aeruginosa: a XAS and XPS study 254
New shuttle vectors for gene cloning and expression in multidrug-resistant Acinetobacter species 254
INTRACELLULAR LEVELS AND ACTIVITY OF PVDS, THE MAJOR IRON STARVATION SIGMA FACTOR OF PSEUDOMONAS AERUGINOSA 253
*NO dissociation represents the rate limiting step for O2-mediated oxidation of ferrous nitrosylated Mycobacterium leprae truncated hemoglobin O 252
A NEW SOLID MEDIUM FOR ISOLATING AND ENUMERATING THIOBACILLUS-FERROOXIDANS 251
Identification of FDA-approved drugs as antivirulence agents targeting the pqs quorum sensing system of Pseudomonas aeruginosa 251
A new point-of-care test for the rapid detection of urinary tract infections 251
ANTIFUNGAL ACTIVITY OF OVOTRANSFERRIN TOWARDS GENUS CANDIDA 249
S-palmitoylation modulates human estrogen receptor-[alpha] functions 248
Mycobacterial truncated hemoglobins: From genes to functions 247
5-fluorocitosina come agente antibatterico. 246
Cell-surface signaling in Pseudomonas: stress responses, iron transport, and pathogenicity 245
CO sniffing through heme-based sensor proteins 245
Repurposing of gallium-based drugs for antibacterial therapy 245
Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections 245
A putative de-N-acetylase of the PIG-L superfamily affects fluoroquinolone tolerance in Pseudomonas aeruginosa. 242
Pyochelin potentiates the inhibitory activity of gallium on Pseudomonas aeruginosa 241
Molecular epidemiology of methicillin-resistant Staphylococcus aureus from dairy farms in North-eastern Italy 241
Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity 240
Synthesis of new linear guanidines and macrocyclic amidinourea derivatives endowed with high antifungal activity against Candida spp. and Aspergillus spp 240
The contribution of active iron-uptake to Acinetobacter baumannii pathogenicity 239
Anthrax toxin: a tripartite lethal combination 236
Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates 236
Antimicrobial activity of gallium compounds on ESKAPE pathogens 236
Amplified fragment-length polymorphism analysis 233
Functional analysis of PvdS, an iron starvation sigma factor of Pseudomonas aeruginosa 232
Pyoverdine synthesis and its regulation in fluorescent pseudomonads 231
The truncated hemoglobin from Mycobacterium leprae 231
IUBMB Life Mini-Theme Issue on the Biology of Acinetobacter Introduction 231
Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy 229
Pyochelin potentiates the inhibitory activity of gallium on Pseudomonas aeruginosa. 229
The Genomics of Acinetobacter baumannii: Insights into Genome Plasticity, Antimicrobial Resistance and Pathogenicity 229
Sicca syndrome associated with Tropheryma whipplei intestinal infection 229
Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections 229
Identification of Legionella spp. by 19 European reference laboratories: results of the European Working Group for Legionella Infections External Quality Assessment Scheme using DNA sequencing of the macrophage infectivity potentiator gene and dedicated online tools 229
Unravelling the Genome-Wide Contributions of Specific 2-Alkyl-4-Quinolones and PqsE to Quorum Sensing in Pseudomonas aeruginosa 228
Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78 227
Anthrax toxin: a tripartite lethal combination 227
The Gac/Rsm and cyclic-di-GMP signalling networks coordinately regulate iron uptake in Pseudomonas aeruginosa 227
Yersinia pseudotuberculosis septicemia and HIV 226
Different responses of pyoverdine genes to autoinduction in Pseudomonas aeruginosa and the group Pseudomonas fluorescens-Pseudomonas putida 226
Iron transport and regulation, cell signalling and genomics: lessons from Escherichia coli and Pseudomonas 225
In situ pilot semi commercial bioleaching test at the San Valentino di Predoi Mine (Northern Italy). 225
Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity 225
Functional and spectroscopic characterization of Chlamydomonas reinhardtii truncated hemoglobins 224
Ferrous Campylobacter jejuni truncated hemoglobin P displays an extremely high reactivity for cyanide: a comparative study 223
Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol 223
The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit 223
Strategy for identification of Bacillus cereus and Bacillus thuringiensis strains closely related to Bacillus anthracis 221
Understanding the etiology of rosy discoloration on ancient wall paintings: a molecular approach. 221
In silico Selection and Experimental Validation of FDA-Approved Drugs as Anti-quorum Sensing Agents 221
Pyoverdine siderophores: from biogenesis to biosignificance 219
An essential transcriptional regulator: The case of Pseudomonas aeruginosa fur 219
Geometrical-optics approach to increase the accuracy in LED-based photometers for point-of-care testing 219
Biosensore per la rilevazione di 3OC12-HSL, kit comprendenti il biosensore e usi di esso 218
Totale 28.919
Categoria #
all - tutte 233.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 233.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.849 174 493 110 86 736 115 592 143 362 128 322 588
2022/20235.403 627 792 403 586 476 1.061 34 457 563 38 226 140
2023/20242.893 230 204 202 125 262 364 282 435 46 82 191 470
2024/20259.906 124 243 991 246 205 400 3.106 1.851 831 485 665 759
2025/202618.431 1.784 1.966 1.276 2.152 1.813 872 1.996 400 3.321 1.803 523 525
2026/202785 85 0 0 0 0 0 0 0 0 0 0 0
Totale 76.771